Martin Studenčan
Acute coronary syndromes are a major health care problem and represent a large number of hospitalizations annually throughout Europe. Patients without persistent ST-segment elevations should receive baseline treatment including aspirin, low-molecular-weight heparin, clopidogrel, betablockers and nitrates. Clinical examination, biochemistry and electrocardiogram enable simple risk stratification of patients presenting without ST elevation and selection of those high risk patients who benefit from invasive strategy with interventional or surgical revascularization. In all cases, an agressive management of risk factors: no smoking, regular exercise. Aspirin, clopidogrel for at least 9 months, beta-blockers and statins must be continued during follow-up.